Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Physical Medicine and Rehabilitation · Hypermobility Spectrum Disorder

Is Treatment Different for HSD vs. Hypermobile EDS?

At a Glance

Treatment for hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) usually focuses on symptoms, function, and individual health needs. The diagnosis alone should not limit rehabilitation, pain care, pacing, or evaluation of related conditions.

The short answer is no: having a diagnosis of hypermobility spectrum disorder (HSD) instead of hypermobile Ehlers-Danlos syndrome (hEDS) should not reduce the medical treatment you receive. While the two labels categorize patients based on the strictness of the 2017 diagnostic criteria, they are not reliable measures of symptom severity. Management often overlaps significantly, and both conditions are treated using a symptom-based approach tailored to your specific needs [1][2]. You should not be denied appropriate care, rehabilitation, or symptom management simply because you do not meet every strict criterion for hEDS.

What Overlaps and What May Differ

While an HSD diagnosis can sometimes feel invalidating after a long search for answers, HSD is a legitimate and often complex condition. It is important to know that the diagnostic label does not dictate how severe your condition is or what care you are eligible for.

Feature Hypermobility Spectrum Disorder (HSD) Hypermobile EDS (hEDS)
Symptom Severity Can be mild to severe and disabling [2] Can be mild to severe and disabling [2]
Treatment Goals Pacing, rehabilitation, pain care, symptom management [1] Pacing, rehabilitation, pain care, symptom management [1]
Phenotype (Presentation) Highly variable; can be localized to a few joints or systemic (body-wide) [3] Typically systemic, involving multiple joints and connective tissues [1]
Diagnostic Reassessment Can be reassessed if new symptoms emerge [4] Diagnosed using strict 2017 criteria; pediatric patients may be reassessed at biological maturity [4]

Symptom-Based Management for HSD and hEDS

Because HSD and hEDS can affect multiple parts of the body, your care team will focus on treating the specific symptoms you experience. The overall approach is usually similar, but the specific evaluation and treatments depend on your individual findings, phenotype, and comorbidities.

Stabilization-Focused Rehabilitation

Physical therapy is central to care for both HSD and hEDS, focusing on improving function and participation in daily life rather than promising to permanently correct joint laxity [5]. Observational studies suggest that patients with both diagnoses can experience improvements when given coordinated physical therapy, though individual responses vary [6]. Therapy typically includes:

  • Therapeutic exercise and motor-function training to gradually build muscle strength around loose joints without forcing end-range stretching [7].
  • Active stabilization techniques, which rely on your own muscles to support joints. These are generally the foundation of rehab, though passive treatments (like manual therapy) can sometimes be used as short-term adjuncts [8].
  • The careful use of braces, taping, or compression garments to reduce pain and support proprioception (your body’s ability to sense where your joints are in space) [9][10]. These devices should be selected and periodically reviewed with a clinician to avoid skin irritation, impaired circulation, or over-reliance. (Note: Joint compression sleeves differ from medical compression garments used for blood pressure regulation).

Pacing and Occupational Support

Managing fatigue and daily function is critical. Care guidelines recommend activity pacing—learning to balance activity and rest to avoid “boom-and-bust” cycles and symptom flares [11]. Occupational therapy can help you adapt your environment at home and work to maintain your independence and reduce physical strain [11][1].

Pain Management

Chronic pain is common in both HSD and hEDS and requires a multimodal (combined) approach [12]. Management typically includes:

  • Physical rehabilitation and psychological support [1]. Psychological support is intended to help the nervous system, improve sleep, and manage pain-related disability—it does not mean your pain is imagined or purely psychological.
  • Over-the-counter pain relievers, like acetaminophen or NSAIDs [13]. However, these should be used with caution: NSAIDs can increase gastrointestinal bleeding and kidney risks, while excessive acetaminophen can cause liver injury. Always check with a pharmacist or clinician, especially if you have other health conditions, and follow the product label. Keep in mind these medicines may help pain but do not correct joint instability.
  • Prescription medications targeting nerve-related or widespread pain, such as SNRIs (serotonin-norepinephrine reuptake inhibitors) [13], which require individualized specialist supervision.
  • Medical consensus advises against the long-term use of opioids for hypermobility-related pain [13].

Treating Autonomic and Associated Conditions

Many people with systemic HSD and hEDS experience autonomic nervous system issues (problems with automatic body functions like heart rate), such as Postural Orthostatic Tachycardia Syndrome (POTS), as well as gastrointestinal problems [14][15].

Dizziness and a racing heart on standing do not automatically mean you have POTS; they can result from dehydration, anemia, or other causes, and require appropriate clinical assessment [14]. If POTS or orthostatic intolerance is diagnosed, conservative treatment often involves increasing salt and fluid intake, wearing compression garments, or using specialist-prescribed medications [16].

Safety Note: Increasing salt and fluid is not safe for everyone, particularly if you have high blood pressure, kidney disease, or heart conditions. Always consult your doctor first. Seek urgent care if you experience fainting with injury, new chest pain, severe shortness of breath, or sustained or irregular palpitations.

Can My Diagnosis Change Over Time?

Yes, your diagnosis can be revisited if new findings emerge. This does not mean that HSD is merely a provisional diagnosis or a stepping stone to hEDS. Many people remain appropriately diagnosed with HSD and still warrant comprehensive care. However, some features of hEDS may not become apparent until later in life. For instance, pediatric guidelines note that an hEDS diagnosis is often reserved for biologically mature adolescents, using generalized hypermobility categories before then [4]. Reassessment should determine whether full criteria are met or if another connective-tissue, neurologic, or cardiovascular condition better explains your symptoms.

Where to Start

If you are newly diagnosed with HSD or hEDS, a realistic first-step care plan might look like this:

  1. Primary Care Review: Start with a primary care provider to assess your current symptoms, medications, and any red flags.
  2. Physical Therapy: Seek a physical therapist familiar with hypermobility for a baseline assessment of your strength, motor control, and joint stability.
  3. Specialist Referrals: Ask for referrals to autonomic, GI, pain, or other specialists only when your specific symptoms warrant them.
  4. Pacing: Introduce one change at a time and track your function, sleep, and pain flares so you can adjust your care plan safely.

Common questions in this guide

Is treatment usually different for HSD and hypermobile EDS?
Usually, no. Both conditions are managed according to the symptoms, functional limitations, and related health problems a person has, rather than the diagnostic label alone. A diagnosis of HSD should not prevent someone from receiving appropriate rehabilitation or symptom care.
What kind of physical therapy helps with HSD or hEDS?
Physical therapy generally focuses on gradual strengthening, motor control, and active stabilization of loose joints. It should support daily function without forcing joints into extreme ranges of motion. Braces, taping, or compression may be used selectively with clinician guidance.
How can pain, fatigue, and daily activities be managed?
Care may combine physical rehabilitation, activity pacing, occupational therapy, psychological support, and medicines when appropriate. Pacing means balancing activity and rest to reduce symptom flares and boom-and-bust cycles. Pain medicines should be chosen with a clinician or pharmacist because they can have kidney, liver, stomach, or other risks.
Can an HSD diagnosis be reviewed later and become hypermobile EDS?
Yes, clinicians can revisit the diagnosis if new findings appear or if a person reaches a stage when the hypermobile EDS criteria can be assessed more fully. HSD is a legitimate diagnosis and is not simply a temporary step toward hypermobile EDS. Evaluation may also consider other connective-tissue, neurologic, or heart-related conditions.
Could dizziness and a fast heartbeat when standing be POTS?
They could be related to postural orthostatic tachycardia syndrome, or POTS, but they can also have causes such as dehydration or anemia. A clinician should assess the symptoms before recommending treatment. If POTS is diagnosed, care may include fluids, salt, compression, or prescription medicine, but increasing salt or fluids is not safe for everyone.
What if an insurer says I need an hEDS diagnosis for therapy?
Ask your clinician to document your symptoms, functional limitations, examination findings, and the treatment you need. HSD can cause substantial disability, and care should be based on clinical needs rather than the label alone. Your care team may help appeal a denial or identify covered rehabilitation options.

Get notified when new evidence is published on hypermobility syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

    Yew KS, Kamps-Schmitt KA, Borge R

    American family physician 2021; (103(8)):481-492.

    PMID: 33856167
  2. 2

    Severity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders: a pilot study of 105 Italian patients.

    Copetti M, Morlino S, Colombi M, et al.

    Rheumatology (Oxford, England) 2019; (58(10)):1722-1730 doi:10.1093/rheumatology/kez029.

    PMID: 30783660
  3. 3

    Placing joint hypermobility in context: traits, disorders and syndromes.

    Morlino S, Castori M

    British medical bulletin 2023; (147(1)):90-107 doi:10.1093/bmb/ldad013.

    PMID: 37350130
  4. 4

    Pediatric joint hypermobility: a diagnostic framework and narrative review.

    Tofts LJ, Simmonds J, Schwartz SB, et al.

    Orphanet journal of rare diseases 2023; (18(1)):104 doi:10.1186/s13023-023-02717-2.

    PMID: 37143135
  5. 5

    The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.

    Engelbert RH, Juul-Kristensen B, Pacey V, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):158-167 doi:10.1002/ajmg.c.31545.

    PMID: 28306230
  6. 6

    Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?

    Aubry-Rozier B, Schwitzguebel A, Valerio F, et al.

    Rheumatology international 2021; (41(10)):1785-1794 doi:10.1007/s00296-021-04968-3.

    PMID: 34398260
  7. 7

    Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.

    Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P

    Disability and rehabilitation 2024; (46(10)):1936-1953 doi:10.1080/09638288.2023.2216028.

    PMID: 37231592
  8. 8

    Managing Patients With Hypermobility Disorders: They've Seen You, but Have You Seen Them?

    Mintken PE, Dommerholt J, Francomano CA

    The Journal of orthopaedic and sports physical therapy 2026; (56(8)):478-481 doi:10.2519/jospt.2026.13979.

    PMID: 42538787
  9. 9

    The Effectiveness of Conservative Interventions on Pain, Function, and Quality of Life in Adults with Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorders and Shoulder Symptoms: A Systematic Review.

    Higo A, Palmer S, Liaghat B, et al.

    Archives of rehabilitation research and clinical translation 2024; (6(3)):100360 doi:10.1016/j.arrct.2024.100360.

    PMID: 39372240
  10. 10

    Compression garments in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.

    Boulu X, Karam JD, Schmidt J

    BMC musculoskeletal disorders 2025; (26(1)):1066 doi:10.1186/s12891-025-09318-z.

    PMID: 41286814
  11. 11

    Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.

    Bennett SE, Walsh N, Moss T, Palmer S

    Disability and rehabilitation 2022; (44(18)):5231-5240 doi:10.1080/09638288.2021.1933618.

    PMID: 34101520
  12. 12

    Pharmacotherapeutic management of chronic pain in joint hypermobility and Ehlers-Danlos syndromes: a clinical perspective.

    Castori M

    Expert opinion on pharmacotherapy 2026; 1-16 doi:10.1080/14656566.2026.2753024.

    PMID: 42899629
  13. 13

    Hypermobility spectrum disorders: A review.

    Carroll MB

    Rheumatology and immunology research 2023; (4(2)):60-68 doi:10.2478/rir-2023-0010.

    PMID: 37637226
  14. 14

    AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.

    Aziz Q, Harris LA, Goodman BP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025; (23(8)):1291-1302 doi:10.1016/j.cgh.2025.02.015.

    PMID: 40387691
  15. 15

    Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Darakjian AA, Bhutani M, Fairweather D, et al.

    Rheumatology advances in practice 2024; (8(4)):rkae134 doi:10.1093/rap/rkae134.

    PMID: 39660107
  16. 16

    Cardiovascular autonomic dysfunction in Ehlers-Danlos syndrome-Hypermobile type.

    Hakim A, O'Callaghan C, De Wandele I, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):168-174 doi:10.1002/ajmg.c.31543.

    PMID: 28160388

This page is for informational purposes only and does not constitute medical advice. Your clinician should tailor HSD or hEDS rehabilitation, pain treatment, and specialist referrals to your symptoms and other health conditions.